Top Markets
#1 Cash Cat Cash Cat +12.09%
#2 Siacoin Siacoin +11.51%
#3 0G 0G +9.75%
#4 Seeker Seeker +9.52%
#5 Arbitrum Arbitrum +8.67%
#6 Metis Metis +5.28%
#7 Story Story +3.96%
#8 MarsCoin MarsCoin +3.88%
#9 Cryptopia Cryptopia +3.87%
#10 Metronome Synth ETH Metronome Synth ETH +3.75%
Coin of the day
Cash Cat Cash Cat
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Carlsmed, Inc. Carlsmed, Inc.

Carlsmed, Inc.

CARL
Rang in Aktien #14030
Carlsmed, Inc., a commercial-stage medical technology company, designs,... Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Aktienkurs
$16.23
Zuletzt synchronisiert: 2026-08-31
Marktkapitalisierung
$441.21M
Veränderung (1 Tag)
-3.85%
Veränderung (1 Jahr)
22.03%
Land
US
Handel Carlsmed, Inc. (CARL)

Kategorie

Healthcare
Kursverlauf für Carlsmed, Inc. (CARL)
Höchster Schlusskurs: $15.09 am 2026-08-01

Niedrigster Schlusskurs: $14.45 am 2025-07-01
Kursverlauf der Aktie von Carlsmed, Inc. von 2025 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -7.94%
2025 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $110.55 -16.67%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $324.35 -17.13%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $90.86 -2.10%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $48.34 -54.18%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $90.89 11.73%
US